Trial intelligence / Profile preview

Ibuprofen for Post-Immunization Cardio-respiratory Events in Preterm Infants

NCT02726178Phase 2Completed

Sponsor
Centre Hospitalier Universitaire Sainte-Justine
Start
Feb 2010
Primary completion
Mar 2011
Modality
Small Molecules
01

Overview

A Phase 2 trial of ibuprofen in cardiovascular disease (CVD), Respiratory Disease (RD), sponsored by Centre Hospitalier Universitaire Sainte-Justine. Started Feb 2010; status: completed.

02

Drugs

ibuprofen
03

Conditions

cardiovascular disease (CVD)Respiratory Disease (RD)

Beyond the preview

Go deeper on NCT02726178.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02726178.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call